Intangible Assets (Tables)

12 Months Ended

Mar. 31, 2020

Intangible Assets, Net (Excluding Goodwill) [Abstract]

Reconciliation of the Activity Affecting Intangible Assets

A reconciliation of the activity affecting intangible assets, net for each of 2020 and 2019 is as follows:


	Year Ended March 31, 2020
(In thousands)	Indefinite- Lived Tradenames		Finite-Lived Tradenames and Customer Relationships		Totals
Gross Carrying Amounts
Balance – March 31, 2019	$	2,273,191	$	390,283	$	2,663,474
Additions ^(a)	2,760		—		2,760



Effects of foreign currency exchange rates	(10,620)		(482)		(11,102)
Balance – March 31, 2020	$	2,265,331	$	389,801	$	2,655,132

Accumulated Amortization
Balance – March 31, 2019	$	—	$	156,264	$	156,264
Additions	—		19,633		19,633

Effects of foreign currency exchange rates	—		(156)		(156)
Balance – March 31, 2020	$	—	$	175,741	$	175,741

Intangible assets, net – March 31, 2020	$	2,265,331	$	214,060	$	2,479,391

Intangible Assets, net by Reportable Segment:
North American OTC Healthcare	$	2,195,617	$	209,604	$	2,405,221
International OTC Healthcare	69,714		4,456		74,170

Intangible assets, net – March 31, 2020	$	2,265,331	$	214,060	$	2,479,391

(a) Amount relates to the acquisition of additional rights to an existing tradename.


	Year Ended March 31, 2019
(In thousands)	Indefinite- Lived Tradenames		Finite-Lived Tradenames and Customer Relationships		Totals
Gross Carrying Amounts
Balance – March 31, 2018	$	2,490,303	$	441,314	$	2,931,617

Reclassifications	(25,152)		25,152		—
Reductions	(30,562)		(34,889)		(65,451)
Tradename impairment	(154,967)		(40,953)		(195,920)
Effects of foreign currency exchange rates	(6,431)		(341)		(6,772)
Balance – March 31, 2019	$	2,273,191	$	390,283	$	2,663,474

Accumulated Amortization
Balance – March 31, 2018	$	—	$	150,701	$	150,701
Additions	—		21,767		21,767
Reductions	—		(16,136)		(16,136)
Effects of foreign currency exchange rates	—		(68)		(68)
Balance – March 31, 2019	$	—	$	156,264	$	156,264

Intangible assets, net – March 31, 2019	$	2,273,191	$	234,019	$	2,507,210

Intangible Assets, net by Reportable Segment:
North American OTC Healthcare	$	2,195,617	$	228,743	$	2,424,360
International OTC Healthcare	77,574		5,276		82,850

Intangible assets, net – March 31, 2019	$	2,273,191	$	234,019	$	2,507,210

Schedule of Expected Amortization Expense

At March 31, 2020, finite-lived intangible assets are expected to be amortized over their estimated useful life, which ranges from a period of 10 to 30 years, and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):


(In thousands)
Year Ending March 31,	Amount
2021	19,606
2022	19,605
2023	19,605
2024	19,578
2025	17,535
Thereafter	118,131
	$	214,060